Hubbard Broadcasting has announced a new multi-year agreement with Nielsen for Local TV measurement of its services in the Minneapolis-St. Paul Television DMA in addition to the Duluth-Superior and Rochester-Mason City-Austin DMAs that were licensed in November 2024. This new agreement also includes Ad Intel, Nielsen’s comprehensive source of competitive Local media advertising intelligence, Scarborough,…Read More
The Super Bowl remains the most expensive and high-profile advertising event of the year, with national TV spots commanding upwards of $8 million–before production costs. But in an era of fragmented attention spans and evolving viewing habits, brands don’t need a seven-figure ad buy to capitalize on Super Bowl buzz. Below, five industry experts shared…Read More
Buckle up because WeatherTech wants to rock out to close out the football season. The maker of American-made products that protect vehicles and homes is advertising in the Super Bowl for the 12th time in a row, and this time they’re putting four “cougars” in their 70s front and center in a music-inspired ad set…Read More
Brand effectiveness doesn’t live and die in one ad slot. So why, when it comes to the Super Bowl, does the industry focus so much on the Big Game TV ads? We should be considering how the Super Bowl ad game is played these days. Big Game ads can be a punchline for long-planned product…Read More
The Super Bowl is the premier stage for advertisers, a showcase for the best creativity and biggest brand ambitions. To mark Super Bowl 2025, ADWEEK looks back on the best Big Game commercials from the past quarter century. 2000: Budweiser “Wassup?” by DDB Chicago When is a commercial so stupid, it’s brilliant? When it’s Budweiser’s…Read More
Vince Lombardi, arguably the most prolific and influential icon in the history of American football, once proclaimed, “Battles are won in the hearts of men.” However, in the NFL’s case, it is truly in the hearts of women–their influence on the growth of the game is a winning formula. The Super Bowl remains the biggest…Read More
In just a handful of decades, esports has leveled up from a niche, underground hobby to a heavyweight sporting contender commanding attention on a major scale. Global streaming audiences reached 625.8 million in 2024, stealing home from the MLB’s 171 million-strong fan base and even dunking on the NBA’s audience of 155.9 million. Meanwhile, the…Read More
In this episode of the Marketing Vanguard podcast, host Jenny Rooney interviews Chris Bellinger, chief creative officer of PepsiCo Foods. Chris discusses his unique journey from agency life to becoming PepsiCo Foods’ first CCO, managing an extensive brand portfolio including Quaker, Frito-Lay, and numerous other household names. He shares insights on defining creativity in a…Read More
Work on climate problems is actually about efficiency.
It’s easier and cheaper to avoid sloppiness and side effects than it is to clean the mess up later. And energy sources that don’t burn become cheaper over time. The investment in getting started pays off in cost, health and organizational efficiency.
Organizing for empathy can be about market share and effectiveness.
When we acknowledge that the people we’re teaching, leading or selling to see the world differently than we do, we can improve the user experience and deliver better results. Successful leaders serve the people they lead.
Finding resilience and diversity can be about productivity.
There are no all-tuba orchestras, because the mixture of skills and tones in an orchestra is what creates the music. Instead of wasting talent and resources, we can engage with communities and viewpoints ready to produce value. Fairness and opportunity reduce friction, build trust and enhance innovation.
It’s tempting to focus on how much we need to improve, but it’s helpful to show others how the improvements will help them.
Better is possible, and it helps to agree about what better looks like.
[Two pictures, one from NASA 60 years ago, and one from Google Earth just now… names help us see, and seeing helps us create.]
The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligence is taking over drug development,” claim some companies and researchers. Over the past few years, interest in using AI to design drugs and optimise clinical trials has driven a surge in research and investment. AI-driven platforms like AlphaFold, which won the 2024 Nobel Prize for its ability to predict the structure of proteins and design new ones, showcase AI’s potential to accelerate drug development. AI in drug discovery is “nonsense,” warn some industry veterans.…
This story continues at The Next WebRead More
Notifications
